Management of acute cancer treatment-induced diarrhea
- PMID: 14702928
- DOI: 10.1053/j.soncn.2003.09.009
Management of acute cancer treatment-induced diarrhea
Abstract
Objectives: To describe the dietary and pharmacologic management of acute CTID.
Data sources: Primary and secondary literature, and clinical experience.
Conclusion: When dietary strategies do not work, or when patients present with grade 3/4 diarrhea, pharmacologic intervention is required. First-line therapy should be initiated quickly with loperamide or diphenoxylate/atropine in recommended doses. Somatostatin analogues are effective as second-line therapy or as first-line therapy for patients with grade 3/4 diarrhea.
Implications for nursing practice: Oncology nurses should strive to match treatment with the severity of symptoms of CTID. Whatever therapy is chosen, the goal must be to quickly control this debilitating and potentially life-threatening side effect so that primary chemotherapy and/or radiation therapy may be resumed and completed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical